Why Refer/Choose Northside Hospital’s Immunotherapy Program?
Northside Hospital Cancer Institute has been named a 2026 top 50 US hospital for cancer care by US News & World Report and ranks in the top 6% of all US cancer programs.
All four Northside hospitals received a High Performing designation for the treatment of multiple myeloma, leukemia, and non-Hodgkin lymphoma patients.
Immunotherapy Program
How is Immunotherapy Different from Conventional Cancer Treatment
Why Refer/Choose Northside Hospital’s Immunotherapy Program
Immunotherapy Patients Have Access To
How Does CAR T-Cell Therapy Work
CAR T-Cell Treatment
The Blood and Marrow Transplant Group of Georgia physicians, experts in administering CAR T-cell therapy and other immunotherapy cancer treatments (TIL therapy), leads Northside Hospital’s Immunotherapy Program.
The program has participated in novel CAR T-cell therapy clinical trials and has the experience to care for patients who may develop mild to severe immunological side effects.
With access to state-of-the-art diagnostic testing, facilities, comprehensive patient-centered care, and a highly trained team, the Immunotherapy Program at Northside Hospital provides patients with exceptional quality care that results in outstanding survival outcomes and patient satisfaction.
